Search results for " Glucose"

showing 10 items of 566 documents

Photocatalytic Solar Light H2 Production by Aqueous Glucose Reforming

2018

Photocatalytic Solar Light H2 Production by Aqueous Glucose Reforming

Solar photocatalysis H2 production glucose reformingSettore CHIM/07 - Fondamenti Chimici Delle Tecnologie
researchProduct

Lifelong exposure to low dose xeno-hormones in rats : multi-generational effects of xeno-hormone mixtures on taste preferences, maternal behavior, an…

2012

During the last decade, the issue of health-related endocrine disruptors (ED) has been extended to the toxicity of mixtures. The objective of this study was to define the effects of lifelong exposure to ED mixtures, at low doses defined as "non-harmful" by the authorities. In this aim, the effects of mixtures combining genistein, vinclozolin and bisphenol A, have been investigated in the rat by using an integrative and multi-generational experimental approach which takes into account maternal behavior, feeding behavior and development. Our results show that these mixtures could: a) reduce maternal behavior, b) change taste preferences (sweet, salty), c) affect the development from the in ut…

Submandibular gland[SDV.SA] Life Sciences [q-bio]/Agricultural sciencesDimorphisme sexuel[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyTolérance au glucoseXéno-hormonesXeno-hormonesAdipose tissueTissu adipeuxGlucose toleranceProtéines salivairesSalivary proteinsSexual dimorphismCholesterolCholestérolHistone acetylationGustineGlande submandibulaireAcétylation des histones
researchProduct

Ras, Rap, and Rac Small GTP-binding Proteins Are Targets for Clostridium sordellii Lethal Toxin Glucosylation

1996

Lethal toxin (LT) from Clostridium sordellii is one of the high molecular mass clostridial cytotoxins. On cultured cells, it causes a rounding of cell bodies and a disruption of actin stress fibers. We demonstrate that LT is a glucosyltransferase that uses UDP-Glc as a cofactor to covalently modify 21-kDa proteins both in vitro and in vivo. LT glucosylates Ras, Rap, and Rac. In Ras, threonine at position 35 was identified as the target amino acid glucosylated by LT. Other related members of the Ras GTPase superfamily, including RhoA, Cdc42, and Rab6, were not modified by LT. Incubation of serum-starved Swiss 3T3 cells with LT prevents the epidermal growth factor-induced phosphorylation of m…

ThreonineUridine Diphosphate GlucoseRHOABacterial ToxinsMolecular Sequence DataClostridium sordelliimacromolecular substancesCDC42GTPaseBiologyCell morphologyBiochemistryGTP PhosphohydrolasesProto-Oncogene Proteins p21(ras)MiceGTP-binding protein regulatorsGTP-Binding ProteinsAnimalsHumansAmino Acid SequenceMolecular BiologyClostridiumEpidermal Growth FactorKinase3T3 CellsCell Biologybiology.organism_classificationMolecular biologyActinsrac GTP-Binding ProteinsActin CytoskeletonKineticsGlucoserap GTP-Binding ProteinsGlucosyltransferasesCalcium-Calmodulin-Dependent Protein Kinasesbiology.proteinPhosphorylationGuanosine TriphosphateHeLa CellsJournal of Biological Chemistry
researchProduct

TiO2 Photocatalytic glucose conversion to H2 and high value chemicals

2015

In this work it is reported the conversion of glucose in aqueous dispersion of various TiO2 based photocatalysts. Aerobic and anaerobic conditions were used to study the distribution of the products both in the liquid (arabinose, gluconic acid, fructose and formic acid) and gas (H2 and CO2) phases. Commercial and home prepared bare and Pt-supported TiO2 samples were used as the photocatalysts.

TiO2 photocatalyst glucose conversion high value chemicalsSettore CHIM/07 - Fondamenti Chimici Delle Tecnologie
researchProduct

Evaluation of an Algorithm for Retrospective Hypoglycemia Detection Using Professional Continuous Glucose Monitoring Data.

2014

Background: People with type 1 diabetes (T1D) are unable to produce insulin and thus rely on exogenous supply to lower their blood glucose. Studies have shown that intensive insulin therapy reduces the risk of late-diabetic complications by lowering average blood glucose. However, the therapy leads to increased incidence of hypoglycemia. Although inaccurate, professional continuous glucose monitoring (PCGM) can be used to identify hypoglycemic events, which can be useful for adjusting glucose-regulating factors. New pattern classification approaches based on identifying hypoglycemic events through retrospective analysis of PCGM data have shown promising results. The aim of this study was to…

Type 1 diabetesbusiness.industryContinuous glucose monitoringEndocrinology Diabetes and MetabolismInsulinmedicine.medical_treatmentBiomedical EngineeringBioengineeringOriginal ArticlesHypoglycemiamedicine.diseaseDiabetes mellitusInternal MedicinemedicineRetrospective analysisFalse positive paradoxCalibration algorithmbusinessAlgorithmJournal of diabetes science and technology
researchProduct

ChemInform Abstract: High-Yielding One-Pot Enzyme-Catalyzed Synthesis of UDP-Glucose in Gram Scales.

2010

UDP GlucoseEnzyme catalyzedChemistryOrganic chemistryGeneral MedicineHigh yieldingGramChemInform
researchProduct

Cellular UDP-Glucose Deficiency Caused by a Single Point Mutation in the UDP-Glucose Pyrophosphorylase Gene

1997

We previously isolated a mutant cell that is the only mammalian cell reported to have a persistently low level of UDP-glucose. In this work we obtained a spontaneous revertant whose UDP-glucose level lies between those found in the wild type and the mutant cell. The activity of UDP-glucose pyrophosphorylase (UDPG:PP), the enzyme that catalyzes the formation of UDP-glucose, was in the mutant 4% and in the revertant 56% of the activity found in the wild type cell. Sequence analysis of UDPG: PP cDNAs from the mutant cell showed one missense mutation, which changes amino acid residue 115 from glycine to aspartic acid. The substituted glycine is located within the largest stretch of strictly con…

Uridine Diphosphate GlucoseDNA ComplementaryMagnetic Resonance SpectroscopyUTP-Glucose-1-Phosphate UridylyltransferaseMolecular Sequence DataMutantDeoxyglucoseBiologymedicine.disease_causeBiochemistryProtein Structure SecondaryCell LineCricetulusCricetinaeAspartic acidmedicineAnimalsPoint MutationMissense mutationAmino Acid SequenceMolecular Biologychemistry.chemical_classificationMutationSequence Homology Amino AcidPoint mutationWild typeCell BiologyMolecular biologyEnzymeBiochemistrychemistryGlycineJournal of Biological Chemistry
researchProduct

High yielding one-pot enzyme-catalyzed synthesis of UDP-glucose in gram scales

2001

Abstract Uridine diphosphoglucose is an important cofactor of glucosylating enzymes. A simple and high yielding one-pot enzymatic synthesis of UDPG on a gram scale from glucose via hexokinase, phosphoglucomutase and UDPG pyrophosphorylase (UGPase) is described. Repetitive addition of substrate was used to avoid inhibition of UGPase. The approach allows recovery of active enzymes and their re-use. The synthesis of UDP-[4-13C]-glucose on a 0.5 g scale resulted in a final yield of 70% and a purity of >95% after chromatographic purification.

Uridine Diphosphate GlucoseMagnetic Resonance SpectroscopyUTP-Glucose-1-Phosphate UridylyltransferaseBiochemistryHigh yieldingCatalysisCofactorAnalytical Chemistrychemistry.chemical_compoundHexokinaseCarbon RadioisotopesGramchemistry.chemical_classificationHexokinaseChromatographyMolecular StructurebiologyOrganic ChemistrySubstrate (chemistry)General MedicineGlucoseEnzymePhosphoglucomutasechemistryBiochemistryYield (chemistry)biology.proteinPhosphoglucomutaseCarbohydrate Research
researchProduct

UDP-glucose deficiency in a mutant cell line protects against glucosyltransferase toxins from Clostridium difficile and Clostridium sordellii.

1996

Abstract We have previously isolated a fibroblast mutant cell with high resistance to the two Rho-modifying glucosyltransferase toxins A and B of Clostridium difficile. We demonstrate here a low level of UDP-glucose in the mutant, which explains its toxin resistance since: (i) to obtain a detectable toxin B-mediated Rho modification in lysates of mutant cells, addition of UDP-glucose was required, and it promoted the Rho modification dose-dependently; (ii) high pressure liquid chromatography analysis of nucleotide extracts of cells indicated that the level of UDP-glucose in the mutant (0.8 nmol/106 cells) was lower than in the wild type (3.7 nmol/106 cells); and (iii) sensitivity to toxin B…

Uridine Diphosphate GlucoseMicroinjectionsMutantBacterial ToxinsClostridium difficile toxin AClostridium sordelliiClostridium difficile toxin Bmedicine.disease_causeBiochemistryMicrobiologyCell LineCricetulusBacterial ProteinsGTP-Binding ProteinsCricetinaemedicineAnimalsMolecular BiologyClostridiumbiologyToxinClostridioides difficileWild typeCell BiologyClostridium difficilebiology.organism_classificationGlucosyltransferasesMutationbiology.proteinGlucosyltransferaseThe Journal of biological chemistry
researchProduct

VEGF-targeted therapy stably modulates the glycolytic phenotype of tumor cells

2014

Abstract Anti-VEGF therapy perturbs tumor metabolism, severely impairing oxygen, glucose, and ATP levels. In this study, we investigated the effects of anti-VEGF therapy in multiple experimental tumor models that differ in their glycolytic phenotypes to gain insights into optimal modulation of the metabolic features of this therapy. Prolonged treatments induced vascular regression and necrosis in tumor xenograft models, with highly glycolytic tumors becoming treatment resistant more rapidly than poorly glycolytic tumors. By PET imaging, prolonged treatments yielded an increase in both hypoxic and proliferative regions of tumors. A selection for highly glycolytic cells was noted and this met…

Vascular Endothelial Growth Factor ACancer ResearchPathologymedicine.medical_specialtyNecrosismedicine.medical_treatmentAngiogenesis InhibitorsMice SCIDBiologySCIDAntibodies Monoclonal HumanizedAntibodiesCell LineTargeted therapyMiceRandom AllocationCell Line TumorNeoplasmsMonoclonalAngiogenesis Inhibitors; Animals; Antibodies Monoclonal Humanized; Bevacizumab; Cell Line Tumor; Female; Glycolysis; Humans; MCF-7 Cells; Mice; Mice Inbred BALB C; Mice SCID; Molecular Targeted Therapy; Neoplasms; Phenotype; Random Allocation; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor AssaysmedicineAnimalsHumansGlycolysisMolecular Targeted Therapycancer-cellAnti-VEGF therapyHumanizedInbred BALB CMED/36 - DIAGNOSTICA PER IMMAGINI E RADIOTERAPIAMice Inbred BALB CTumorpositron emission tomography antiangiogenesis glucose metabolism hypoxiaXenograft Model Antitumor AssaysPhenotypeBlockadeBevacizumabVascular endothelial growth factor APhenotypeOncologyCell cultureMonoclonalMCF-7 CellsCancer researchMED/06 - ONCOLOGIA MEDICAFemalemedicine.symptomGlycolysis
researchProduct